Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:01 pm
| PEG Ratio | -9.56 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ansals Buildwell Ltd operates in the construction, contracting, and engineering industry, with its share price reported at ₹104 and a market capitalization of ₹76.4 Cr. The company’s revenue has exhibited significant volatility, with sales recorded at ₹32.67 Cr for the fiscal year ending March 2023, recovering to ₹41.37 Cr in March 2024, and further increasing to ₹48.88 Cr in March 2025. Quarterly sales figures reveal fluctuations, with a peak of ₹24.28 Cr in December 2023 and a low of ₹2.57 Cr in June 2023. This inconsistency in revenue generation reflects the cyclical nature of the construction industry and potential project delays. The trailing twelve months (TTM) revenue stood at ₹39.42 Cr, indicating a recovery from previous lows, yet still signaling the need for sustained growth strategies to stabilize revenue streams. The company’s performance is critical as it operates in a sector typically characterized by a more consistent revenue flow, suggesting that Ansal Buildwell must enhance its project execution capabilities to align with industry standards.
Profitability and Efficiency Metrics
Profitability metrics for Ansal Buildwell Ltd indicate a challenging environment, with an operating profit margin (OPM) recorded at 27.30%, which is relatively strong compared to many peers in the construction sector. However, the company faced significant operating losses in several quarters, with a notable decline in the OPM to -68.87% in June 2023. The net profit for the fiscal year 2025 was reported at ₹7.96 Cr, with an earnings per share (EPS) of ₹10.78. The interest coverage ratio (ICR) stood at 3.97x, suggesting that the company can comfortably meet its interest obligations, although a ratio above 5 is often preferred in the industry. The ROE was recorded at 6.13%, and ROCE stood at 9.68%, both indicating moderate efficiency in utilizing equity and capital employed. The company’s performance is marred by inconsistent quarterly profits, which reflect the need for improved operational efficiency and cost management strategies to enhance profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ansal Buildwell Ltd reveals a mixed picture of financial health. The total borrowings stood at ₹42.05 Cr, which, when compared to reserves of ₹122.29 Cr, indicates a manageable debt level. The current ratio was reported at 1.27, suggesting that the company maintains sufficient liquidity to cover short-term obligations, while the quick ratio of 0.23 indicates a reliance on inventory for liquidity. The price-to-book value (P/BV) ratio was recorded at 0.58x, which is below the typical sector range, indicating that the stock may be undervalued relative to its book value. The total debt to equity ratio stood at 0.29, suggesting a conservative leverage position. However, the cash conversion cycle of 9,196.89 days raises concerns about operational efficiency, as extended cycles can hinder cash flow and operational agility. The company’s ability to manage its balance sheet effectively will be crucial to navigate the competitive landscape of the construction sector.
Shareholding Pattern and Investor Confidence
Investor confidence in Ansal Buildwell Ltd is reflected in its shareholding pattern, where promoters hold 54.83% of the shares, indicating a strong commitment from the founding members. Institutional investment remains negligible, with domestic institutional investors (DIIs) holding only 0.03%. The public holds 45.14% of the shares, which suggests a relatively stable retail investor base. Over the past quarters, the number of shareholders has declined from 7,523 in September 2022 to 6,521 in June 2025, which may indicate a lack of confidence or interest among smaller investors. The low involvement of foreign institutional investors (FIIs) is a potential risk factor, as it limits the company’s access to larger pools of capital and market validation. Such a shareholder structure may affect liquidity and market perception, particularly if the company fails to deliver consistent financial performance in the coming periods.
Outlook, Risks, and Final Insight
Looking ahead, Ansal Buildwell Ltd faces several opportunities and risks. The recovery in revenue signals potential for growth, but the company must address its inefficiencies, particularly concerning the lengthy cash conversion cycle and operational losses in certain quarters. The construction sector’s cyclical nature poses inherent risks, especially regarding project timelines and cost overruns. Moreover, the reliance on promoter holdings without significant institutional backing could hinder broader market confidence. If the company successfully stabilizes its operational metrics and enhances project execution, it could see a positive shift in investor sentiment. Conversely, continued volatility in earnings and cash flow could exacerbate existing challenges, impacting its market position. The ability to diversify its project portfolio and improve operational efficiencies will be pivotal in navigating the competitive landscape of the construction industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ansal Buildwell Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 56.3 Cr. | 36.4 | 49.9/22.5 | 5.36 | 39.4 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 773 Cr. | 394 | 409/220 | 94.2 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 172 Cr. | 24.9 | 35.7/18.0 | 43.5 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 35.1 Cr. | 47.4 | 92.7/38.0 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 26.8 Cr. | 53.7 | 78.1/45.6 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| Industry Average | 16,422.05 Cr | 246.52 | 81.18 | 131.48 | 0.15% | 16.68% | 21.32% | 21.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.72 | 14.12 | 5.28 | 4.56 | 2.57 | 11.73 | 24.28 | 2.79 | 19.24 | 5.82 | 8.60 | 15.22 | 9.78 |
| Expenses | 7.27 | 13.53 | 6.55 | 2.56 | 4.34 | 6.47 | 7.12 | 4.78 | 11.40 | 7.22 | 6.12 | 10.19 | 7.11 |
| Operating Profit | 1.45 | 0.59 | -1.27 | 2.00 | -1.77 | 5.26 | 17.16 | -1.99 | 7.84 | -1.40 | 2.48 | 5.03 | 2.67 |
| OPM % | 16.63% | 4.18% | -24.05% | 43.86% | -68.87% | 44.84% | 70.68% | -71.33% | 40.75% | -24.05% | 28.84% | 33.05% | 27.30% |
| Other Income | 0.69 | 0.80 | 0.47 | 0.98 | 0.61 | 0.69 | 0.61 | 0.89 | 0.75 | 0.86 | 0.93 | 1.74 | 0.84 |
| Interest | 1.35 | 0.45 | 0.78 | 1.15 | 0.94 | 0.85 | 0.94 | 1.35 | 0.96 | 1.09 | 1.12 | 1.42 | 1.20 |
| Depreciation | 0.62 | 0.53 | 0.44 | -0.82 | 0.55 | 0.52 | 0.58 | 0.47 | 0.40 | 0.60 | 0.58 | 0.57 | 0.59 |
| Profit before tax | 0.17 | 0.41 | -2.02 | 2.65 | -2.65 | 4.58 | 16.25 | -2.92 | 7.23 | -2.23 | 1.71 | 4.78 | 1.72 |
| Tax % | 58.82% | 7.32% | 1.49% | 86.42% | 2.26% | 17.90% | 0.18% | 164.73% | 24.76% | -21.97% | 25.15% | 90.38% | 28.49% |
| Net Profit | 0.06 | 0.33 | -2.18 | -1.10 | -3.26 | 6.62 | 16.09 | -5.02 | 7.78 | -4.67 | 0.32 | 4.53 | 1.29 |
| EPS in Rs | 0.08 | 0.45 | -2.95 | -1.49 | -4.42 | 8.97 | 21.79 | -6.80 | 10.54 | -6.32 | 0.43 | 6.14 | 1.75 |
Last Updated: August 19, 2025, 11:40 pm
Below is a detailed analysis of the quarterly data for Ansal Buildwell Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9.78 Cr.. The value appears to be declining and may need further review. It has decreased from 15.22 Cr. (Mar 2025) to 9.78 Cr., marking a decrease of 5.44 Cr..
- For Expenses, as of Jun 2025, the value is 7.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.19 Cr. (Mar 2025) to 7.11 Cr., marking a decrease of 3.08 Cr..
- For Operating Profit, as of Jun 2025, the value is 2.67 Cr.. The value appears to be declining and may need further review. It has decreased from 5.03 Cr. (Mar 2025) to 2.67 Cr., marking a decrease of 2.36 Cr..
- For OPM %, as of Jun 2025, the value is 27.30%. The value appears to be declining and may need further review. It has decreased from 33.05% (Mar 2025) to 27.30%, marking a decrease of 5.75%.
- For Other Income, as of Jun 2025, the value is 0.84 Cr.. The value appears to be declining and may need further review. It has decreased from 1.74 Cr. (Mar 2025) to 0.84 Cr., marking a decrease of 0.90 Cr..
- For Interest, as of Jun 2025, the value is 1.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.42 Cr. (Mar 2025) to 1.20 Cr., marking a decrease of 0.22 Cr..
- For Depreciation, as of Jun 2025, the value is 0.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.57 Cr. (Mar 2025) to 0.59 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.72 Cr.. The value appears to be declining and may need further review. It has decreased from 4.78 Cr. (Mar 2025) to 1.72 Cr., marking a decrease of 3.06 Cr..
- For Tax %, as of Jun 2025, the value is 28.49%. The value appears to be improving (decreasing) as expected. It has decreased from 90.38% (Mar 2025) to 28.49%, marking a decrease of 61.89%.
- For Net Profit, as of Jun 2025, the value is 1.29 Cr.. The value appears to be declining and may need further review. It has decreased from 4.53 Cr. (Mar 2025) to 1.29 Cr., marking a decrease of 3.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.75. The value appears to be declining and may need further review. It has decreased from 6.14 (Mar 2025) to 1.75, marking a decrease of 4.39.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:57 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 123 | 96 | 51 | 72 | 44 | 63 | 73 | 188 | 33 | 41 | 49 | 49 |
| Expenses | 121 | 103 | 77 | 40 | 58 | 42 | 52 | 58 | 165 | 30 | 23 | 35 | 32 |
| Operating Profit | 24 | 19 | 20 | 11 | 14 | 2 | 11 | 15 | 23 | 3 | 19 | 14 | 17 |
| OPM % | 17% | 16% | 20% | 21% | 20% | 5% | 17% | 20% | 12% | 8% | 45% | 29% | 34% |
| Other Income | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 4 | 4 |
| Interest | 7 | 5 | 9 | 11 | 11 | 12 | 9 | 8 | 5 | 4 | 4 | 5 | 5 |
| Depreciation | 1 | 2 | 1 | 1 | 1 | 1 | 4 | 1 | 4 | 1 | 2 | 2 | 2 |
| Profit before tax | 18 | 14 | 12 | 0 | 5 | -7 | 1 | 7 | 17 | 1 | 15 | 11 | 14 |
| Tax % | 39% | 38% | 37% | 431% | 74% | 12% | 28% | 3% | 42% | 196% | 37% | 53% | |
| Net Profit | 11 | 9 | 8 | -1 | 1 | -9 | 0 | 7 | 11 | -3 | 15 | 8 | 11 |
| EPS in Rs | 14.55 | 12.15 | 10.18 | -1.33 | 1.42 | -11.53 | 0.62 | 9.05 | 15.37 | -3.82 | 19.65 | 10.78 | 14.62 |
| Dividend Payout % | 10% | 8% | 10% | 0% | 35% | 0% | 0% | 6% | 0% | 0% | 5% | 9% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -11.11% | -112.50% | 200.00% | -1000.00% | 100.00% | 57.14% | -127.27% | 600.00% | -46.67% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7.07% | -101.39% | 312.50% | -1200.00% | 1100.00% | -42.86% | -184.42% | 727.27% | -646.67% |
Ansal Buildwell Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -5% |
| 3 Years: | -36% |
| TTM: | -32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 80% |
| 3 Years: | -11% |
| TTM: | -94% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 35% |
| 3 Years: | 6% |
| 1 Year: | -48% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:21 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 29.51 | 28.07 | 74.20 | 46.90 | 33.71 | 41.68 | 59.39 | 9.05 | 1.91 | 1.34 | 0.53 | 1.49 |
| Inventory Days | 9,554.63 | |||||||||||
| Days Payable | 359.24 | |||||||||||
| Cash Conversion Cycle | 29.51 | 28.07 | 74.20 | 46.90 | 33.71 | 41.68 | 59.39 | 9.05 | 1.91 | 1.34 | 0.53 | 9,196.89 |
| Working Capital Days | 181.33 | 278.10 | 453.17 | 910.20 | 584.03 | 827.06 | 528.54 | 369.35 | 78.06 | 680.62 | 596.95 | 573.49 |
| ROCE % | 18.84% | 12.59% | 11.96% | 6.24% | 8.92% | 2.54% | 6.63% | 10.31% | 15.34% | 3.50% | 13.01% | 9.85% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 10.78 | 19.65 | -3.82 | 15.37 | 9.05 |
| Diluted EPS (Rs.) | 10.78 | 19.65 | -3.82 | 15.37 | 9.05 |
| Cash EPS (Rs.) | 10.27 | 15.91 | -0.55 | 18.53 | 11.36 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 175.62 | 166.11 | 147.48 | 150.92 | 133.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 175.62 | 166.11 | 147.48 | 150.92 | 133.34 |
| Revenue From Operations / Share (Rs.) | 66.20 | 56.02 | 44.25 | 254.19 | 98.82 |
| PBDIT / Share (Rs.) | 24.68 | 29.07 | 7.73 | 35.56 | 23.15 |
| PBIT / Share (Rs.) | 21.78 | 26.20 | 6.70 | 30.59 | 21.31 |
| PBT / Share (Rs.) | 15.57 | 20.68 | 1.65 | 23.23 | 9.82 |
| Net Profit / Share (Rs.) | 7.36 | 13.04 | -1.58 | 13.57 | 9.52 |
| NP After MI And SOA / Share (Rs.) | 10.78 | 19.65 | -3.82 | 15.37 | 9.05 |
| PBDIT Margin (%) | 37.28 | 51.88 | 17.47 | 13.99 | 23.42 |
| PBIT Margin (%) | 32.89 | 46.76 | 15.14 | 12.03 | 21.56 |
| PBT Margin (%) | 23.51 | 36.91 | 3.73 | 9.13 | 9.93 |
| Net Profit Margin (%) | 11.12 | 23.27 | -3.57 | 5.33 | 9.63 |
| NP After MI And SOA Margin (%) | 16.28 | 35.06 | -8.63 | 6.04 | 9.15 |
| Return on Networth / Equity (%) | 6.13 | 11.82 | -2.58 | 10.18 | 6.78 |
| Return on Capital Employeed (%) | 9.68 | 12.54 | 3.63 | 17.46 | 12.32 |
| Return On Assets (%) | 1.49 | 2.80 | -0.59 | 2.40 | 1.86 |
| Long Term Debt / Equity (X) | 0.07 | 0.06 | 0.02 | 0.01 | 0.18 |
| Total Debt / Equity (X) | 0.29 | 0.25 | 0.27 | 0.23 | 0.40 |
| Asset Turnover Ratio (%) | 0.09 | 0.08 | 0.06 | 0.50 | 0.20 |
| Current Ratio (X) | 1.27 | 1.26 | 1.21 | 1.15 | 1.45 |
| Quick Ratio (X) | 0.23 | 0.23 | 0.22 | 0.19 | 0.44 |
| Inventory Turnover Ratio (X) | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 9.27 | 0.00 | 0.00 | 3.25 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 7.30 | 0.00 | 0.00 | 2.45 | 0.00 |
| Earning Retention Ratio (%) | 90.73 | 0.00 | 0.00 | 96.75 | 0.00 |
| Cash Earning Retention Ratio (%) | 92.70 | 0.00 | 0.00 | 97.55 | 0.00 |
| Interest Coverage Ratio (X) | 3.97 | 5.27 | 1.53 | 4.83 | 2.01 |
| Interest Coverage Ratio (Post Tax) (X) | 2.19 | 3.36 | 0.68 | 2.84 | 1.83 |
| Enterprise Value (Cr.) | 91.96 | 112.87 | 72.70 | 84.49 | 53.53 |
| EV / Net Operating Revenue (X) | 1.88 | 2.73 | 2.23 | 0.45 | 0.73 |
| EV / EBITDA (X) | 5.05 | 5.26 | 12.74 | 3.22 | 3.13 |
| MarketCap / Net Operating Revenue (X) | 1.55 | 2.59 | 1.62 | 0.37 | 0.42 |
| Retention Ratios (%) | 90.72 | 0.00 | 0.00 | 96.74 | 0.00 |
| Price / BV (X) | 0.58 | 0.87 | 0.48 | 0.62 | 0.31 |
| Price / Net Operating Revenue (X) | 1.55 | 2.59 | 1.62 | 0.37 | 0.42 |
| EarningsYield | 0.10 | 0.13 | -0.05 | 0.16 | 0.21 |
After reviewing the key financial ratios for Ansal Buildwell Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.78. This value is within the healthy range. It has decreased from 19.65 (Mar 24) to 10.78, marking a decrease of 8.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.78. This value is within the healthy range. It has decreased from 19.65 (Mar 24) to 10.78, marking a decrease of 8.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.27. This value is within the healthy range. It has decreased from 15.91 (Mar 24) to 10.27, marking a decrease of 5.64.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.62. It has increased from 166.11 (Mar 24) to 175.62, marking an increase of 9.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.62. It has increased from 166.11 (Mar 24) to 175.62, marking an increase of 9.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 66.20. It has increased from 56.02 (Mar 24) to 66.20, marking an increase of 10.18.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.68. This value is within the healthy range. It has decreased from 29.07 (Mar 24) to 24.68, marking a decrease of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 21.78. This value is within the healthy range. It has decreased from 26.20 (Mar 24) to 21.78, marking a decrease of 4.42.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.57. This value is within the healthy range. It has decreased from 20.68 (Mar 24) to 15.57, marking a decrease of 5.11.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 13.04 (Mar 24) to 7.36, marking a decrease of 5.68.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.78. This value is within the healthy range. It has decreased from 19.65 (Mar 24) to 10.78, marking a decrease of 8.87.
- For PBDIT Margin (%), as of Mar 25, the value is 37.28. This value is within the healthy range. It has decreased from 51.88 (Mar 24) to 37.28, marking a decrease of 14.60.
- For PBIT Margin (%), as of Mar 25, the value is 32.89. This value exceeds the healthy maximum of 20. It has decreased from 46.76 (Mar 24) to 32.89, marking a decrease of 13.87.
- For PBT Margin (%), as of Mar 25, the value is 23.51. This value is within the healthy range. It has decreased from 36.91 (Mar 24) to 23.51, marking a decrease of 13.40.
- For Net Profit Margin (%), as of Mar 25, the value is 11.12. This value exceeds the healthy maximum of 10. It has decreased from 23.27 (Mar 24) to 11.12, marking a decrease of 12.15.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.28. This value is within the healthy range. It has decreased from 35.06 (Mar 24) to 16.28, marking a decrease of 18.78.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 15. It has decreased from 11.82 (Mar 24) to 6.13, marking a decrease of 5.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.68. This value is below the healthy minimum of 10. It has decreased from 12.54 (Mar 24) to 9.68, marking a decrease of 2.86.
- For Return On Assets (%), as of Mar 25, the value is 1.49. This value is below the healthy minimum of 5. It has decreased from 2.80 (Mar 24) to 1.49, marking a decrease of 1.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.29, marking an increase of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has increased from 1.26 (Mar 24) to 1.27, marking an increase of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.12, marking an increase of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.27. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 9.27, marking an increase of 9.27.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.30. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 7.30, marking an increase of 7.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 90.73. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 90.73, marking an increase of 90.73.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.70. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.70, marking an increase of 92.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.97. This value is within the healthy range. It has decreased from 5.27 (Mar 24) to 3.97, marking a decrease of 1.30.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.19. This value is below the healthy minimum of 3. It has decreased from 3.36 (Mar 24) to 2.19, marking a decrease of 1.17.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91.96. It has decreased from 112.87 (Mar 24) to 91.96, marking a decrease of 20.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.73 (Mar 24) to 1.88, marking a decrease of 0.85.
- For EV / EBITDA (X), as of Mar 25, the value is 5.05. This value is within the healthy range. It has decreased from 5.26 (Mar 24) to 5.05, marking a decrease of 0.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For Retention Ratios (%), as of Mar 25, the value is 90.72. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 90.72, marking an increase of 90.72.
- For Price / BV (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.58, marking a decrease of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to 0.10, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ansal Buildwell Ltd:
- Net Profit Margin: 11.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.68% (Industry Average ROCE: 16.68%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.13% (Industry Average ROE: 21.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.23
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.52 (Industry average Stock P/E: 81.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.29
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 118, Upper First Floor, New Delhi Delhi 110001 | info@ansalabl.com http://www.ansalabl.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shobhit Charla | Whole Time Director |
| Mrs. Ritu Ansal | Woman Director |
| Ms. Suman Dahiya | Independent Director |
| Mr. Vijay Talwar | Independent Director |